"There is no shortage of early-stage innovators with bold ideas that could lead to better management of T1D or to prevention," Sean Sullivan, a program officer at the Helmsley Charitable Trust, says in a press release.
"There is, however, a shortage of funding for those ideas, as well as the know-how to get them to market."
That's why Helmsley and the StartUp Health organization have teamed up to create the T1D Moonshot, an ambitious three-year initiative designed to help people with type 1 diabetes (T1D) live "safer, better, and more fulfilling lives today while funding transformative advancements in research and technology," per the press release.
Sullivan's group says it's looking for 25 to 30 early-stage companies with " promising, but unproven, approaches for the prevention, management, and cure of T1D" to take part in the fellowship program, which will offer education, support, and investment to help them get their ideas to market.
"It will take the passion and commitment of a global army of Health Transformers to solve the myriad of challenges facing people and families living with T1D," StartUp Health's CEO and co-founder Steven Krein says in the Read the Entire Article
A customized collection of grant news from foundations and the federal government from around the Web.